Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17–48.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Qi J, Li M, Wang L, Hu Y, Liu W, Long Z, et al. National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data. Lancet Public Health. 2023;8(12):e943–55.
Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864–84.
Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–62.
Article CAS PubMed Google Scholar
Yang G, Yan H, Tang Y, Yuan F, Cao M, Ren Y, et al. Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: a comprehensive review. Chin J Cancer Res. 2023;35(3):266–82.
CAS PubMed PubMed Central Google Scholar
Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, et al. Novel cellular therapies for hepatobiliary malignancies. Hepatobiliary Pancreat Dis Int. 2022;21(5):450–4.
Khan AA, Liu ZK, Xu X. Recent advances in immunotherapy for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2021;20(6):511–20.
Article CAS PubMed Google Scholar
Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut. 2016;65(6):1035–41.
Article CAS PubMed Google Scholar
Kim SJ, Kim JM. Prediction models of hepatocellular carcinoma recurrence after liver transplantation: a comprehensive review. Clin Mol Hepatol. 2022;28(4):739–53.
Article PubMed PubMed Central Google Scholar
Terrault NA, Francoz C, Berenguer M, Charlton M, Heimbach J, Liver. Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023;21(8):2150-66.
Wong RJ, Singal AK. Trends in Liver Disease etiology among adults awaiting liver transplantation in the United States, 2014–2019. JAMA Netw Open. 2020;3(2):e1920294.
Lu TF, Hua XW, Cui XL, Xia Q. Liver transplantation for hepatocellular carcinoma: recent advances in China. J Dig Dis. 2014;15(2):51–3.
Article CAS PubMed Google Scholar
Kim JM, Kim DG, Kim J, Lee K, Lee KW, Ryu JH, et al. Outcomes after liver transplantation in Korea: incidence and risk factors from Korean transplantation registry. Clin Mol Hepatol. 2021;27(3):451–62.
Article PubMed PubMed Central Google Scholar
He Z, She X, Liu Z, Gao X, Lu LU, Huang J, et al. Advances in post-operative prognostic models for hepatocellular carcinoma. J Zhejiang Univ Sci B. 2023;24(3):191–206.
Wang LY, Zheng SS. Advances in predicting the prognosis of hepatocellular carcinoma recipients after liver transplantation. J Zhejiang Univ Sci B. 2018;19(7):497–504.
Article PubMed PubMed Central Google Scholar
Zhao JW, Shu X, Chen XX, Liu JX, Liu MQ, Ye J, et al. Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram. Hepatobiliary Pancreat Dis Int. 2022;21(6):543–50.
Zhang FM, Wu HF, Shi HP, Yu Z, Zhuang CL. Sarcopenia and malignancies: epidemiology, clinical classification and implications. Ageing Res Rev. 2023;91:102057.
Tao J, Fang J, Chen L, Liang C, Chen B, Wang Z et al. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer. J Cachexia Sarcopenia Muscle. 2023.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020;145:102839.
Article CAS PubMed Google Scholar
Xiao J, Mazurak VC, Olobatuyi TA, Caan BJ, Prado CM. Visceral adiposity and cancer survival: a review of imaging studies. Eur J Cancer Care (Engl). 2018;27(2):e12611.
Article CAS PubMed Google Scholar
Cheng E, Kirley J, Cespedes Feliciano EM, Caan BJ. Adiposity and cancer survival: a systematic review and meta-analysis. Cancer Causes Control. 2022;33(10):1219–46.
Article PubMed PubMed Central Google Scholar
Yu JJ, Shen F, Chen TH, Liang L, Han J, Xing H, et al. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma. Br J Surg. 2019;106(3):276–85.
Article CAS PubMed Google Scholar
Gomez-Perez SL, Haus JM, Sheean P, Patel B, Mar W, Chaudhry V, et al. Measuring abdominal circumference and skeletal muscle from a single cross-sectional computed tomography image: a step-by-step guide for Clinicians Using National Institutes of Health ImageJ. JPEN J Parenter Enter Nutr. 2016;40(3):308–18.
Caan BJ, Cespedes Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of Muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast Cancer. JAMA Oncol. 2018;4(6):798–804.
Article PubMed PubMed Central Google Scholar
McGovern J, Dolan RD, Horgan PG, Laird BJ, McMillan DC. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle. 2021;12(6):1408–17.
Article PubMed PubMed Central Google Scholar
Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol. 2015;63(1):131–40.
Article CAS PubMed Google Scholar
Zhao T, Su Z, Li Y, Zhang X, You Q. Chitinase-3 like-protein-1 function and its role in diseases. Signal Transduct Target Ther. 2020;5(1):201.
Article CAS PubMed PubMed Central Google Scholar
Wang S, Hu M, Qian Y, Jiang Z, Shen L, Fu L, et al. CHI3L1 in the pathophysiology and diagnosis of liver diseases. Biomed Pharmacother. 2020;131:110680.
Article CAS PubMed Google Scholar
Berres ML, Papen S, Pauels K, Schmitz P, Zaldivar MM, Hellerbrand C, et al. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection. J Hepatol. 2009;50(2):370–6.
Article CAS PubMed Google Scholar
Xiao XQ, Hassanein T, Li QF, Liu W, Zheng YH, Chen J. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker? Hepatobiliary Pancreat Dis Int. 2011;10(6):605–10.
Wang S, Chen S, Jin M, Hu M, Huang W, Jiang Z, et al. Diagnostic and prognostic value of serum chitinase 3-like protein 1 in hepatocellular carcinoma. J Clin Lab Anal. 2022;36(2):e24234.
Article CAS PubMed PubMed Central Google Scholar
Zhu CB, Chen LL, Tian JJ, Su L, Wang C, Gai ZT, et al. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma a
留言 (0)